Table 1.
Clinical indicators at baseline in different groups (X ± S)
| Groups | OP | T2DM | OP + T2DM | Control |
|---|---|---|---|---|
| Number (N) | 90 | 96 | 90 | 78 |
| Age (yr) | 60.0 ± 3.0 | 60.4 ± 3.2 | 60.2 ± 3.3 | 60.5 ± 2.7 |
| menopausal period (years) | 7.4 ± 1.7 | 7.3 ± 1.6 | 7.3 ± 1.5 | 7.5 ± 1.4 |
| BMI (kg/m2) | 20.5 ± 1.7 | 24.2 ± 1.7 | 21.4 ± 1.8 | 21.8 ± 1.5 |
| TRACP-5b (U/L) | 3.5 ± 1.0 | 2.9 ± 0.4 | 3.2 ± 0.7 | 3.0 ± 0.4 |
| BALP (μg/l) | 21.4 ± 7.2 | 17.3 ± 5.6 | 17.3 ± 5.5 | 15.8 ± 4.4 |
| HbA1c (%) | 5.0 ± 0.5 | 7.6 ± 1.0 | 7.7 ± 1.0 | 5.0 ± 0.5 |
| FINS (uU/ml) | 6.6 ± 1.6 | 15.2 ± 5.4 | 9.2 ± 1.2 | 6.5 ± 1.7 |
| L2-4 (g/m2) | 0.78 ± 0.10 | 1.03 ± 0.13 | 0.80 ± 0.10 | 0.95 ± 0.14 |
| femoral neck (g/m2) | 0.61 ± 0.08 | 0.76 ± 0.10 | 0.64 ± 0.11 | 0.73 ± 0.11 |